Scientific Literature Search

Source record

Targeting CNS transporters for treatment of neurodegenerative diseases.

Jedlitschky G, Grube M, Mosyagin I, Kroemer HK, Vogelgesang S.

Curr Pharm Des · 2014-01-01

DOI: 10.2174/13816128113199990460PMID: 23789959

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Emerging trends in the epidemiology of melanoma.

Nikolaou V, Stratigos AJ.

Br J Dermatol · 2014-01-01

DOI: 10.1111/bjd.12492PMID: 23815297

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Therapeutic potential of cannabinoids in neurodegenerative disorders: a selective review.

Velayudhan L, Van Diepen E, Marudkar M, Hands O, Suribhatla S, Prettyman R, Murray J, Baillon S, Bhattacharyya S.

Curr Pharm Des · 2014-01-01

DOI: 10.2174/13816128113199990434PMID: 23829360

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

The NOX1/4 inhibitor GKT136901 as selective and direct scavenger of peroxynitrite.

Schildknecht S, Weber A, Gerding HR, Pape R, Robotta M, Drescher M, Marquardt A, Daiber A, Ferger B, Leist M.

Curr Med Chem · 2014-01-01

DOI: 10.2174/09298673113209990179PMID: 23848532

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Disrupting self-assembly and toxicity of amyloidogenic protein oligomers by "molecular tweezers" - from the test tube to animal models.

Attar A, Bitan G.

Curr Pharm Des · 2014-01-01

DOI: 10.2174/13816128113199990496PMID: 23859557

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

The incidental suggestive meningioma presenting as high 18F FP-CIT uptake on PET/CT study.

Song IU, Lee SH, Chung YA.

Clin Nucl Med · 2014-01-01

DOI: 10.1097/rlu.0b013e3182815d16PMID: 23877508

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Epigenetic drugs in cognitive disorders.

Peedicayil J.

Curr Pharm Des · 2014-01-01

DOI: 10.2174/13816128113199990526PMID: 23888959

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Using cerebrospinal fluid marker profiles in clinical diagnosis of dementia with Lewy bodies, Parkinson's disease, and Alzheimer's disease.

Kaerst L, Kuhlmann A, Wedekind D, Stoeck K, Lange P, Zerr I.

J Alzheimers Dis · 2014-01-01

DOI: 10.3233/jad-130995PMID: 23948928

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

3,4-dihydroxybenzalacetone protects against Parkinson's disease-related neurotoxin 6-OHDA through Akt/Nrf2/glutathione pathway.

Gunjima K, Tomiyama R, Takakura K, Yamada T, Hashida K, Nakamura Y, Konishi T, Matsugo S, Hori O.

J Cell Biochem · 2014-01-01

DOI: 10.1002/jcb.24643PMID: 23959789

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Identification of three novel LRRK2 mutations associated with Parkinson's disease in a Calabrian population.

Anfossi M, Colao R, Gallo M, Bernardi L, Conidi ME, Frangipane F, Vasso F, Puccio G, Clodomiro A, Mirabelli M, Curcio SA, Torchia G, Smirne N, Di Lorenzo R, Maletta R, Bruni AC.

J Alzheimers Dis · 2014-01-01

DOI: 10.3233/jad-130689PMID: 23963289

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Cerebrovascular profile assessment in Parkinson's disease patients.

Perju-Dumbravă L, Muntean ML, Muresanu DF.

CNS Neurol Disord Drug Targets · 2014-01-01

DOI: 10.2174/1871527313666140618110409PMID: 24040791

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Approaching neurological diseases to reduce mobility limitations in older persons.

Lauretani F, Ceda GP, Pelliccioni P, Ruffini L, Nardelli A, Cherubini A, Maggio M.

Curr Pharm Des · 2014-01-01

DOI: 10.2174/13816128113196660687PMID: 24050168

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

187.286 articles found

Targeting CNS transporters for treatment of neurodegenerative diseases.

Emerging trends in the epidemiology of melanoma.

Therapeutic potential of cannabinoids in neurodegenerative disorders: a selective review.

The NOX1/4 inhibitor GKT136901 as selective and direct scavenger of peroxynitrite.

Disrupting self-assembly and toxicity of amyloidogenic protein oligomers by "molecular tweezers" - from the test tube to animal models.

The incidental suggestive meningioma presenting as high 18F FP-CIT uptake on PET/CT study.

Epigenetic drugs in cognitive disorders.

Using cerebrospinal fluid marker profiles in clinical diagnosis of dementia with Lewy bodies, Parkinson's disease, and Alzheimer's disease.

3,4-dihydroxybenzalacetone protects against Parkinson's disease-related neurotoxin 6-OHDA through Akt/Nrf2/glutathione pathway.

Identification of three novel LRRK2 mutations associated with Parkinson's disease in a Calabrian population.

Cerebrovascular profile assessment in Parkinson's disease patients.

Approaching neurological diseases to reduce mobility limitations in older persons.

Filters